DB
PCVX icon

Danske Bank’s Vaxcyte PCVX Stock Holding History

Danske Bank’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6K Hold
200
– – ﹤0.01% 800
2026
Q1 		$11.6K Sell
200
-1,900
-90% -$103K ﹤0.01% 789
2025
Q4 		$96.9K Hold
2,100
– – ﹤0.01% 790
2025
Q3 		$75.6K Hold
2,100
– – ﹤0.01% 920
2025
Q2 		$68.3K Buy
2,100
+1,900
+950% +$62.3K ﹤0.01% 940
2025
Q1 		$7.55K Hold
200
– – ﹤0.01% 1126
2024
Q4 		$16.4K Sell
200
-500
-71% -$49.6K ﹤0.01% 1027
2024
Q3 		$80K Buy
+700
New +$63.1K ﹤0.01% 1073

Other funds holding PCVX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $751B AUM 15.65% 1-Year Est. Return

Danske Bank's PCVX Position: Q2 2026 in Review

Danske Bank held its Vaxcyte (PCVX) position steady in Q2 2026 at 200 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #800.

Danske Bank first reported a position in PCVX in Q3 2024 and has held it in 8 quarters since. The position peaked at $96.9K in Q4 2025. 259 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

  • Danske Bank held 200 shares of Vaxcyte worth $11.6K as of Q2 2026.
  • Danske Bank left its Vaxcyte share count unchanged in Q2 2026.
  • Vaxcyte made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #800 holding.
  • Danske Bank first reported a position in Vaxcyte in Q3 2024 and has held it in 8 quarters since.
  • Danske Bank's Vaxcyte position peaked at $96.9K in Q4 2025.
  • 259 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.